This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea

This study has been completed.
Nielsen, Jens OD, M.D.
Information provided by:
Central Jutland Regional Hospital Identifier:
First received: March 26, 2007
Last updated: March 28, 2007
Last verified: March 2007
The purpose of this study is to determine whether sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia concerning post- operative nausea and vomiting.

Condition Intervention
Nausea Vomiting Procedure: Sevoflurane-remifentanil anaesthesia

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention
Official Title: Postoperative Nausea and Vomiting Are Similar When Propofol or Sevoflurane Are Used as Adjuvant to Remifentanil During Anaesthesia for Gynaecological Surgery

Resource links provided by NLM:

Further study details as provided by Central Jutland Regional Hospital:

Primary Outcome Measures:
  • Nausea, incidence and intensity ( VAS score )in PACU and surgical ward
  • Vomiting, incidence in PACU and surgical ward
  • Total PONV after 24 hours

Estimated Enrollment: 160
Study Start Date: January 2002
Study Completion Date: May 2005
Detailed Description:

Propofol and sevoflurane anaesthesia are used world wide at the anaesthetists discretion.

Propofol is superior to inhalational anaesthetics as anaesthesia for patients at risk of post operative nausea and vomiting (PONV) as PONV is diminished. However, when remifentanil is used as adjuvant to sevoflurane, the total dose of the latter is reduced.

Therefore, we wanted to investigate if sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia with emphasis on nausea, vomiting and total PONV during 24 hours.

In the post anaesthesia care unit (PACU) and in the surgical ward nausea was scored on a visual analogue score. Vomiting was registered.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Females younger than 50 years
  • ASA I-II
  • Scheduled to gynaecological laparotomies or laparoscopies

Exclusion Criteria:

  • Medication known to act anti-emetic
  • ASA status greater than II
  • Malignant hyperthermia
  • Allergy to the drugs used.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00452855

Viborg Hospital
Viborg, Denmark, 8800
Sponsors and Collaborators
Central Jutland Regional Hospital
Nielsen, Jens OD, M.D.
Principal Investigator: Jens Ole Dich JO Nielsen, MD
  More Information Identifier: NCT00452855     History of Changes
Other Study ID Numbers: PropSevoRemi
Study First Received: March 26, 2007
Last Updated: March 28, 2007

Keywords provided by Central Jutland Regional Hospital:
Post operative
Propofol remifentanil anaesthesia
Sevoflurane remifentanil anaesthesia

Additional relevant MeSH terms:
Postoperative Nausea and Vomiting
Signs and Symptoms, Digestive
Signs and Symptoms
Postoperative Complications
Pathologic Processes
Central Nervous System Depressants
Physiological Effects of Drugs
Hypnotics and Sedatives
Anesthetics, Intravenous
Anesthetics, General
Analgesics, Opioid
Sensory System Agents
Peripheral Nervous System Agents
Platelet Aggregation Inhibitors
Anesthetics, Inhalation processed this record on September 21, 2017